Marathon Trading Investment Management LLC Invests $1.08 Million in The Clorox Company $CLX

Marathon Trading Investment Management LLC purchased a new position in shares of The Clorox Company (NYSE:CLX) in the fourth quarter, Holdings Channel.com reports. The firm purchased 10,663 shares of the company’s stock, valued at approximately $1,075,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Haverford Trust Co raised its stake in shares of Clorox by 2.8% during the 4th quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock worth $310,000 after purchasing an additional 84 shares in the last quarter. Field & Main Bank raised its stake in shares of Clorox by 3.3% during the 4th quarter. Field & Main Bank now owns 3,100 shares of the company’s stock worth $313,000 after purchasing an additional 100 shares in the last quarter. Golden State Wealth Management LLC raised its stake in shares of Clorox by 28.2% during the 4th quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock worth $46,000 after purchasing an additional 100 shares in the last quarter. Fisher Asset Management LLC raised its stake in shares of Clorox by 1.7% during the 3rd quarter. Fisher Asset Management LLC now owns 6,053 shares of the company’s stock worth $746,000 after purchasing an additional 102 shares in the last quarter. Finally, Johnson Financial Group Inc. raised its stake in shares of Clorox by 3.1% during the 3rd quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company’s stock worth $451,000 after purchasing an additional 109 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts recently weighed in on the company. Royal Bank Of Canada cut their price objective on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 9th. Morgan Stanley cut their price objective on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research note on Friday, May 1st. Evercore reissued an “underperform” rating and issued a $110.00 price objective on shares of Clorox in a research note on Friday, May 1st. The Goldman Sachs Group reissued a “sell” rating and issued a $83.00 price objective on shares of Clorox in a research note on Friday, May 1st. Finally, Wells Fargo & Company cut their price objective on Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research note on Monday, May 18th. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Clorox presently has a consensus rating of “Reduce” and a consensus price target of $103.40.

Clorox Stock Down 0.1%

Shares of CLX stock opened at $96.74 on Monday. The stock’s 50 day simple moving average is $96.43 and its 200 day simple moving average is $105.20. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $132.03. The company has a market capitalization of $11.70 billion, a price-to-earnings ratio of 15.70, a PEG ratio of 0.50 and a beta of 0.56.

Clorox (NYSE:CLX) last released its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company’s revenue was up .1% on a year-over-year basis. During the same quarter last year, the firm posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, research analysts predict that The Clorox Company will post 5.61 EPS for the current year.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of the stock in a transaction on Tuesday, May 5th. The shares were purchased at an average price of $85.82 per share, with a total value of $429,100.00. Following the acquisition, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. This represents a 38.46% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.63% of the stock is owned by company insiders.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.